125 related articles for article (PubMed ID: 36639137)
1. The 'Parma At-Risk mental states' (PARMS) program: General description and process analysis after 5 years of clinical activity.
Pelizza L; Leuci E; Quattrone E; Paulillo G; Pellegrini P
Early Interv Psychiatry; 2023 Jun; 17(6):625-635. PubMed ID: 36639137
[TBL] [Abstract][Full Text] [Related]
2. The "Parma-Early Psychosis" program: General description and process analysis after 5 years of clinical activity.
Leuci E; Quattrone E; Pellegrini P; Pelizza L
Early Interv Psychiatry; 2020 Jun; 14(3):356-364. PubMed ID: 31758672
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the gap between child and adult mental health services: The Reggio Emilia experience in an early intervention in psychosis program.
Poletti M; Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Raballo A
Early Interv Psychiatry; 2021 Dec; 15(6):1749-1758. PubMed ID: 33264817
[TBL] [Abstract][Full Text] [Related]
4. The "Reggio Emilia At-Risk Mental States" program: A diffused, "liquid" model of early intervention in psychosis implemented in an Italian Department of Mental Health.
Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
Early Interv Psychiatry; 2019 Dec; 13(6):1513-1524. PubMed ID: 31270956
[TBL] [Abstract][Full Text] [Related]
5. The 'Parma-Early Psychosis' programme: Characterization of help-seekers with first episode psychosis.
Landi G; Leuci E; Quattrone E; Azzali S; Pellegrini C; Pellegrini P; Pelizza L
Early Interv Psychiatry; 2021 Apr; 15(2):380-390. PubMed ID: 32307896
[TBL] [Abstract][Full Text] [Related]
6. Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2-year Italian follow-up study.
Pelizza L; Leuci E; Quattrone E; Azzali S; Pupo S; Paulillo G; Menchetti M; Pellegrini P
Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1177-1191. PubMed ID: 38091031
[TBL] [Abstract][Full Text] [Related]
7. Characterization of young people with first episode psychosis or at ultra-high risk: the Reggio Emilia At-Risk Mental States (ReARMS) program.
Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
Riv Psichiatr; 2019; 54(6):254-263. PubMed ID: 31909752
[TBL] [Abstract][Full Text] [Related]
8. Baseline antipsychotic prescription and short-term outcome indicators in individuals at clinical high-risk for psychosis: Findings from the Parma At-Risk Mental States (PARMS) program.
Pelizza L; Leuci E; Quattrone E; Azzali S; Paulillo G; Pupo S; Poletti M; Raballo A; Pellegrini P; Menchetti M
Early Interv Psychiatry; 2024 Feb; 18(2):71-81. PubMed ID: 37194411
[TBL] [Abstract][Full Text] [Related]
9. Screening schizotypal personality disorder for detection of clinical high risk of psychosis in Chinese mental health services.
Zhang T; Li H; Tang Y; Li H; Zheng L; Guo Q; Zhao S; Zhuo K; Qian Z; Wang L; Dai Y; Chow A; Li C; Jiang K; Wang J; Xiao Z
Psychiatry Res; 2015 Aug; 228(3):664-70. PubMed ID: 26165958
[TBL] [Abstract][Full Text] [Related]
10. [Early detection of psychotic disorders].
Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
[TBL] [Abstract][Full Text] [Related]
11. The significance of at-risk symptoms for psychosis in children and adolescents.
Schimmelmann BG; Walger P; Schultze-Lutter F
Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
[TBL] [Abstract][Full Text] [Related]
12. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
[TBL] [Abstract][Full Text] [Related]
13. A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state.
Kotlicka-Antczak M; Karbownik MS; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Urban-Kowalczyk M
Compr Psychiatry; 2019 Apr; 90():95-101. PubMed ID: 30831438
[TBL] [Abstract][Full Text] [Related]
14. Exploring Identity Disturbance and Psychotic Spectrum Symptoms as Predictors of Borderline and Schizotypal Personality Disorders.
Meisner MW; Lenzenweger MF; Bach B; Vestergaard M; Petersen LS; Haahr UH; Kongerslev M; Simonsen E
Psychopathology; 2021; 54(4):193-202. PubMed ID: 34058737
[TBL] [Abstract][Full Text] [Related]
15. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis of psychotic symptoms in adolescents and young adults with borderline personality disorder].
Dammann G; Walter M
Psychiatr Prax; 2003 Sep; 30(6):304-11. PubMed ID: 12970815
[TBL] [Abstract][Full Text] [Related]
18. Factor-structure of the Italian version of the Scale Of Prodromal Symptoms (SOPS): a comparison with the English version.
Comparelli A; Savoja V; Kotzalidis GD; Woods SW; Mosticoni S; Vassallo F; Soscia F; Piccione R; Palma G; Pucci D; Girardi P; Conti L; Tatarelli R
Epidemiol Psychiatr Sci; 2011 Mar; 20(1):45-54. PubMed ID: 21657115
[TBL] [Abstract][Full Text] [Related]
19. Borderline personality features among individuals at clinical high risk for psychosis (CHR-P): A brief report.
West ML; Guest RM; Carmel A; Madigan R; Yen S
Early Interv Psychiatry; 2023 Feb; 17(2):223-228. PubMed ID: 35959808
[TBL] [Abstract][Full Text] [Related]
20. Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample.
Flückiger R; Ruhrmann S; Debbané M; Michel C; Hubl D; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
J Abnorm Psychol; 2016 Oct; 125(7):923-932. PubMed ID: 27583768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
